Bextra Breaking News!

Did you know?

Health care giant Kaiser Permanente, an HMO serving 2.6 million Californians, stopped prescribing Bextra to its patients.

Out-of-state plaintiffs take on Bextra in St. Clair County
St. Clair Record, IL - Jan 24, 2006
Clair County Circuit Court claiming Bextra caused them or their next of kin strokes or heart problems. ... According to the suit, Bextra was defectively designed. ...

Health Canada bans Bextra
Quesnel Cariboo Observer,  Canada  - Jan 11, 2006
By Alain Saffel. Health Canda has decided to ban the anti-inflammatory drug Bextra after reviewing the safety information on the arthritis and pain drug. ...

Doctors Back Bextra Ban - Forbes Magazine

NEW YORK - This morning, the U.S. Food and Drug Administration announced new labeling for a broad swath of arthritis pain drugs, including Advil, Aleve and Motrin. Pfizer' s blockbuster Celebrex will get the most serious type of warning the FDA can level, and Bextra, another Pfizer arthritis drug, will be removed from the market in the U.S. and in Europe ..

Bextra withdrawn amid skin concerns - BBC News

Sales of a painkiller have been suspended across Europe and the US amid concerns about skin reactions.

There have been 155 reports of adverse reactions to Bextra, commonly used to relieve pain and inflammation from arthritis, worldwide.

Bextra - FDA Wants Strongest Warnings on Painkillers, and Pfizer's Bextra ...

The painkiller Bextra was taken off the market Thursday, and the government wants other drugs in the same class to carry the strongest possible warnings about increased risk of heart attack and stroke among the millions of people who rely on them. Pfizer Inc. suspended sales of Bextra in the United States and the European Union at the request of the Food and Drug Administration and European regulators.

BEXTRA ® Doubles Risk of Heart Attack and Stroke, Study Finds

November 11, 2004

A University of Pennsylvania researcher says patients taking Pfizer's BEXTRA ® may double their risk of suffering a heart attack or stroke. The company called the claim "unsubstantiated" and said a recent analysis found no cardiovascular problems among arthritis patients taking BEXTRA ®.

BEXTRA ® is one of the few alternative COX-2 pain killers for patients who had been using Merck's Vioxx® , withdrawn from the market in September following studies which found the drug increased the risk of heart attack and stroke in patients who took it for more than 18 months.

Last month, Pfizer conceded that BEXTRA ® was linked to increased risk of heart attack and stroke in a study of coronary bypass patients but said the risk did not extend to other users.

The latest finding comes from Garret A. FitzGerald, of the Center for Experimental Therapeutics at the University of Pennsylvania , a prominent COX-2 researcher. He presented his findings at a meeting of the American Heart Association.

FitzGerald, who has not yet published his findings in a peer-reviewed journal, says the patients in his analysis are "the canary in the coal mine" -- an early-warning sign for the millions of patients who have not yet been harmed.

FitzGerald said his findings strongly suggest that patients at risk of heart attack and strokes should avoid COX-2 medications while lower-risk patients should take them only with great caution.

FitzGerald acknowledges limitations in his study but says the Vioxx® withdrawal has put the burden of proof on the drug companies to show conclusively that the COX-2 drugs are safe.

FitzGerald's study did not include Pfizer's other COX-2 drug, Celebrex, a much bigger seller than BEXTRA ®.

FitzGerald's analysis was based on 7,771 patients; 5,930 took BEXTRA ® while 1,841 took a placebo. There were 45 heart attacks and strokes among patients taking BEXTRA ®, seven in the placebo group. That translates into an approximately 2.2 times higher risk of a heart attack or stroke for those taking BEXTRA ®.

With an estimated seven million patients having taken BEXTRA ® since its introduction in 2001, more than 150,000 patients could have experienced ill effects if FitzGerald's analysis is accurate.

Source: http://www.consumeraffairs.com/news04/Vioxx®_BEXTRA ®2.html

BEXTRA ® Report Questions Effects on Heart Patients

By Steve Sternberg, USA TODAY

NEW ORLEANS - A study suggesting arthritis drug BEXTRA ® doubles patients' heart attack and stroke risks drew a sharp rebuttal Wednesday from the drug's maker, Pfizer (PFE) , as its stock price dipped.

The study, discussed at the American Heart Association meeting here, found patients taking BEXTRA ® were more than twice as likely to have a heart attack or stroke than patients taking a placebo.

BEXTRA ®'s risk appeared to pose a slightly higher risk than Vioxx®, a drug in the same class that was pulled from the market in October. The Senate Finance Committee has scheduled a hearing next Thursday on safety questions concerning Vioxx®, made by Merck.

In the BEXTRA ® study, the highest risk was seen in patients who had had bypass operations, indicating that heart patients may be particularly vulnerable to any ill effects.

The study's lead author, Garret FitzGerald of the University of Pennsylvania, said he hopes his findings will prompt the Food and Drug Administration to warn against giving the drug to patients with heart disease - and examine whether the risk posed by Vioxx® extends to every member of its drug class, called Cox-2 inhibitors.

Pfizer's Joseph Feczko said Wednesday that the report drew "unsubstantiated conclusions" about BEXTRA ®'s safety and was "based on information that has not been published in a medical journal or subject to independent scientific review."

FitzGerald, who first described his research Tuesday in a presentation reported by The New York Times , acknowledged that, by itself, his study doesn't carry as much authority as a "gold standard" blind clinical trial, but he said a pattern of evidence has emerged that is difficult to ignore.

Source: http://www.usatoday.com/news/health/2004-11-10-BEXTRA ®-usat_x.htm

CONTACT AN EXPERIENCED BEXTRA LAWYER

Several thousand people have contacted us to help them find an experienced Bextra lawyer. Every month, more than 100,000 people visit our legal help centers seeking help for their family's legal needs. In the past 5 years we have we helped thousands of people get their cases settled with experienced legal representation in each state.

There is NO COST or obligation for this service